Literature DB >> 18824843

Familial Mediterranean fever gene as a possible modifier of Sweet syndrome with chronic myelogenous leukemia.

Takashi Miyoshi1, Kouhei Yamashita, Tatsuharu Ohno, Taisuke Izumi, Akifumi Takaori-Kondo, Masataka Sasada, Takashi Uchiyama.   

Abstract

Sweet syndrome is a multisystem inflammatory disorder characterized by acute fever, as well as painful erythematous plaques infiltrated with mature neutrophils in the absence of vasculitis. The pathogenesis of the disease has not yet been clarified, although several proinflammatory cytokines have been reported to be involved in the disease process. We describe here a patient clinically diagnosed with Sweet syndrome with chronic myelogenous leukemia. The mutational analysis of the patient revealed a compound heterozygous E148Q/R202Q mutation in exon 2 of MEFV gene, which is a causative gene for familial Mediterranean fever. This is the first report to describe MEFV gene mutations in Sweet syndrome. Our results suggest that Sweet syndrome may be mediated though similar inflammatory mechanisms to those of familial Mediterranean fever. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18824843     DOI: 10.1159/000158578

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  8 in total

Review 1.  Neutrophilic dermatoses and autoinflammatory diseases with skin involvement--innate immune disorders.

Authors:  Alexander A Navarini; Takashi K Satoh; Lars E French
Journal:  Semin Immunopathol       Date:  2015-11-30       Impact factor: 9.623

2.  Evaluation of pathergy test positivity in familial Mediterranean fever patients and comparison of clinical manifestations of FMF with Behçet's disease.

Authors:  Fatma Aydin; Tekin Akpolat; Nilgun Senturk; Hasan Bagci; Ahmet Yasar Turanli
Journal:  Clin Rheumatol       Date:  2009-07-29       Impact factor: 2.980

3.  High frequency of MEFV gene mutations in patients with myeloid neoplasm.

Authors:  Cagatay Oktenli; Ozkan Sayan; Serkan Celik; Alev A Erikci; Yusuf Tunca; Hakan M Terekeci; Elcin Erkuvan Umur; Yavuz S Sanisoglu; Deniz Torun; Fatih Tangi; Burak Sahan; Selim Nalbant
Journal:  Int J Hematol       Date:  2010-05-01       Impact factor: 2.490

4.  Clinical evaluation of R202Q alteration of MEFV genes in Turkish children.

Authors:  Elif Comak; Sema Akman; Mustafa Koyun; Cagla Serpil Dogan; Arife Uslu Gokceoglu; Yunus Arikan; Ibrahim Keser
Journal:  Clin Rheumatol       Date:  2014-04-10       Impact factor: 2.980

Review 5.  High frequency of inherited variants in the MEFV gene in patients with hematologic neoplasms: a genetic susceptibility?

Authors:  Cagatay Oktenli; Serkan Celik
Journal:  Int J Hematol       Date:  2012-03-28       Impact factor: 2.490

6.  Alteration in the gene encoding protein tyrosine phosphatase nonreceptor type 6 (PTPN6/SHP1) may contribute to neutrophilic dermatoses.

Authors:  Andrew B Nesterovitch; Zsuzsa Gyorfy; Mark D Hoffman; Ellen C Moore; Nada Elbuluk; Beata Tryniszewska; Tibor A Rauch; Melinda Simon; Sewon Kang; Gary J Fisher; Katalin Mikecz; Michael D Tharp; Tibor T Glant
Journal:  Am J Pathol       Date:  2011-03-04       Impact factor: 4.307

Review 7.  Insights Into the Pathogenesis of Sweet's Syndrome.

Authors:  Michael S Heath; Alex G Ortega-Loayza
Journal:  Front Immunol       Date:  2019-03-12       Impact factor: 7.561

8.  Neuro-Behçet Disease, Neuro-Sweet Disease, and Spectrum Disorders.

Authors:  Kinya Hisanaga
Journal:  Intern Med       Date:  2021-10-05       Impact factor: 1.271

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.